HOME >> MEDICINE >> NEWS
Galileo to support global search and rescue

The detection of emergency beacons will be greatly improved by the introduction of Europe's satellite positioning system, Galileo. The Galileo satellites will carry transponders to relay distress signals to search and rescue organisations.

In connection with this, representatives of the Galileo project attended the recent 21st annual Joint Committee Meeting of COSPAS-SARSAT, the international programme for satellite-aided search and rescue.

The partners in Galileo are committed to developing the Galileo search and rescue component as an integral part of MEOSAR, the future worldwide search and rescue satellite system.

Galileo joined the meeting in a formal capacity as a major contributor to the MEOSAR programme, following the signature of the 'Declaration of Intent to Cooperate on the Development and Evaluation of MEOSAR'. MEOSAR, which stands for Medium Earth Orbit Search And Rescue, is a programme to equip satellites that operate in medium-Earth orbits with payloads that receive signals from distress beacons on Earth. These signals are then relayed to rescue organisations, giving them the location of the emergency.

Existing systems

COSPAS-SARSAT already has systems operating in low-Earth orbit and geostationary orbit. The low-Earth orbit satellites can determine the location of emergency beacons using the Doppler effect as they pass overhead. However, there is a delay in relaying the distress signal because the satellites can only 'see' a part of the Earth's surface at any given time and a beacon is only detected when the satellite passes nearly overhead. Also, the satellites have to store the location of the emergency and transmit it to a ground station once one comes into in range, causing a further delay.

Search and rescue transponders on geostationary satellites can constantly view a large, fixed area of the Earth, thereby eliminating the time delay in detecting distress signals. However
'"/>

Contact: Dominique Detain
dominique.detain@esa.int
33-015-369-7726
European Space Agency
9-Aug-2007


Page: 1 2 3

Related medicine news :

1. New contracts support clinical trials on antibiotic-resistant, community-acquired staph infections
2. Michigan-CDC study supports value of social restrictions during influenza pandemics
3. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
4. Advocates ask fashion industry to support braille clothing tags; talking Web site
5. ACP supports improved access to information on relative strengths and weaknesses
6. Study supports activity of GEMZAR in the treatment of early-stage breast cancer
7. Disadvantaged TB patients urgently need social support to make medical treatment more effective
8. UPMC begins study of heart support device as a bridge to transplantation
9. New research supports early testing for prostate cancer
10. ACP enthusiastically supports introduction of Bipartisan Health CARE Act
11. Psychosocial support for cancer survivors needs strengthening

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Galileo support global search and rescue

(Date:5/19/2013)... Atlanta, GA (PRWEB) May 19, 2013 The ... and 2pm at the Columbus Georgia Convention & Trade Center ... are invited to attend. AMTC auditions are free of charge. ... the starting point for hundreds of successful artists and grads ... new face for European Tombolini , Chris Young - on ...
(Date:5/19/2013)... The Da Vinci robot lawyers at Wright & ... first trial involving a Da Vinci surgical robot lawsuit. ... was filed by the widow of a man who ... robot-assisted prostate removal, according to a report from Bloomberg ... alleges those complication’s hastened his death. (Estate of ...
(Date:5/18/2013)... The American Society for Gastrointestinal Endoscopy (ASGE) will honor ... ninth annual ASGE Crystal Awards on Sunday, May 19, ... year,s event will begin at ... Held in conjunction with Digestive Disease Week (DDW), the ... and scientific pursuit. The event will recognize the 2013 ...
(Date:5/18/2013)... Online watch retailer Time and Gems is offering ... at a fraction of its usual cost. With great deals ... buyers are urged to take advantage of Time and Gems’ ... from a brick-and-mortar store, buyers now have the option of ... unbelievable rates. Although some buyers may have qualms about buying ...
(Date:5/18/2013)... (HealthDay News) -- Just a few extra cups of ... an autoimmune liver disease known as primary sclerosing cholangitis ... Mayo Clinic in Rochester, Minn., found that drinking coffee ... disease, which can lead to cirrhosis of the liver, ... not prove a cause-and-effect relationship. "While rare, ...
Breaking Medicine News(10 mins):Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 2Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 3Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
(Date:5/16/2013)... , May 16, 2013  PTC Therapeutics, Inc., ... on Form S-1 with the U.S. Securities and Exchange ... of its common stock. The number of shares to ... have not been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ... are acting as joint book-running managers for the offering. ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
Cached News: